Incidence and features of dual anti-GBM-positive and ANCA-positive patients

Nephrology

Volumn 16, Issue 8, 2011, Pages 725-729

  De Zoysa, Janak ^a,b   Taylor, Dominic ^a   Thein, Hla ^d   Yehia, Maha ^c  

^a NORTH SHORE HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

ANCA positive vasculitis; Anti GBM disease; Goodpasture's syndrome; Rapidly progressive renal failure

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTON PUMP INHIBITOR;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANEMIA; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CREATININE BLOOD LEVEL; FEMALE; GOODPASTURE SYNDROME; HEMATURIA; HEMOPTYSIS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; MALE; MORTALITY; NEW ZEALAND; PATIENT MONITORING; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RELAPSE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SMOKING; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; FEMALE; HEMATURIA; HUMANS; INCIDENCE; KIDNEY; MALE; MIDDLE AGED; NEW ZEALAND; PROTEINURIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84055176444     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01484.x     Document Type: Article

References (17)

1. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J. Exp. Med. 1967;126:989-1004.
2. Pedchenko V, Bondar O, Fogo AB et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N. Engl. J. Med. 2010;363:343-54.
3. Kallenberg CG. Pathogenesis of ANCA-associated vasculitides. Ann. Rheum. Dis. 2011;70(Suppl 1): i59-63.
4. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 2002;110:955-63.
5. Goodpasture EW. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am. J. Med. Sci. 1919;158:863-71.
6. Statistics New Zealand. [Cited March 2011.] Available from URL: http://www.stats.govt.nz
7. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW. Co-existence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am. J. Kidney Dis. 2005;46:253-62. (Pubitemid 41040353)
8. Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990;37:965-70. (Pubitemid 20089230)
9. Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J. Am. Soc. Nephrol. 1997;8:376-85. (Pubitemid 127454173)
10. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535-40. (Pubitemid 39298387)
11. Salama AD, Dougan T, Levy JB et al. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am. J. Kidney Dis. 2002;39:1162-7. (Pubitemid 34591930)
12. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott D G I. Geoepidemiology of systemic vasculitis: Comparison of the incidence in two regions of Europe. Ann. Rheum. Dis. 2001;60:170-72. (Pubitemid 32102210)
13. O'Donnell JL, Stevanovic VR, Frampton C, Stamp LK, Chapman PT. Wegener's granulomatosis in New Zealand: Evidence for a latitudedependent incidence gradient. Intern. Med. J. 2007;37:242-6. (Pubitemid 46457498)
14. Teague CA, Doak PB, Simpson IJ, Rainer SP, Herdson PB. Goodpasture's syndrome: An analysis of 29 cases. Kidney Int. 1978;13:492-504. (Pubitemid 8373075)
15. Cui Z, Zhao J, Jia XY, Zhu SN, Zhao MH. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients. Am. J. Kidney Dis. 2011;57:575-82.
16. Jayne DR, Gaskin G, Rasmussen N et al. European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J. Am. Soc. Nephrol. 2007;18:2180-88. (Pubitemid 47041083)
17. Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C. Comparison of anti-GBM antibodies in sera with or without ANCA. J. Am. Soc. Nephrol. 1997;8:376-85. (Pubitemid 127454173)